Neuroprotection in Cerebral Ischemia Open access Peer reviewed

Cytoflavin's neuroprotective effect in acute ischemic stroke: a systematic review and meta-analysis

Retnaningsih Retnaningsih, Dodik Tugasworo, Wati Arinta Puspita, Chandra Elvika and 1 more

Frontiers in Stroke | Oct 30, 2026

Scollr summary

What this paper is about

In conclusion, cytoflavin shows promising neuroprotective effects in AIS, however, due to heterogeneity and methodological limitations, further large-scale, high-quality studies are needed to confirm its efficacy and optimize treatment protocols.

Full abstract

Read the full abstract

Acute ischemic stroke (AIS) remains a leading cause of long-term disability globally. While reperfusion therapies are effective, there is a growing need for adjunct neuroprotective strategies to minimize secondary brain injury. Cytoflavin, a metabolic and antioxidant compound, has shown potential neuroprotective effects. However, its clinical efficacy remains underexplored. This systematic review and meta-analysis aim to evaluate the efficacy of Cytoflavin in AIS, focusing on neurological recovery (NIHSS), functional independence (Barthel Index), cognitive performance (MMSE), and infarct volume. A systematic search was conducted across multiple databases for studies evaluating Cytoflavin in AIS. Nine studies were included, with a combined enrollment of 3,254 participants across treatment arms (sample sizes reported per arm); the number of unique participants contributing to each pooled outcome was smaller after correcting for shared control groups and repeated-measures overlap across evaluation time points (e.g., 1,379 for NIHSS). Data were analyzed using random-effects models; where a shared control group was compared against two Cytoflavin dose arms within the same study, the control group was split proportionally between the two comparisons to avoid double-counting participants (unit-of-analysis correction). Risk of bias was assessed using Cochrane Risk of Bias tool and Newcastle-Ottawa Scale. Cytoflavin significantly improved NIHSS scores (MD = −2.63, 95% CI: −3.15 to −2.10; moderate certainty) and Barthel Index (MD = 19.29, 95% CI: 9.52 to 29.07; moderate certainty), and showed improvements of low certainty in MMSE scores (MD = +6.93, 95% CI: 1.39 to 12.47) and mRS scores (MD = −0.41, 95% CI: −0.74 to −0.09), the latter derived from continuous summary statistics for an inherently ordinal scale (see Limitations). For infarct volume, effects diverged by evaluation time point: a marginal increase was observed at Day-10 (MD = +0.17 cm 3 , based on a single study), while a non-significant reduction was observed at Day-21 (MD = −4.73 cm 3 , 95% CI: −11.41 to 1.95; very low certainty). High heterogeneity (I 2 ranging from 0% to 100%) was observed across outcomes and persisted after the unit-of-analysis correction, indicating genuine clinical and methodological diversity across studies. In conclusion, cytoflavin shows promising neuroprotective effects in AIS. However, due to heterogeneity and methodological limitations, further large-scale, high-quality studies are needed to confirm its efficacy and optimize treatment protocols. Systematic review registration: https://www.crd.york.ac.uk/PROSPERO/view/CRD420251112430 , identifier: CRD420251112430.

Direct answer

What can I do from this paper page?

Use this page to scan "Cytoflavin's neuroprotective effect in acute ischemic stroke: a systematic review and meta-analysis" quickly: start with the summary and abstract, then check the authors, source, topics, and related papers. From here, open Scollr to follow Neuroprotection in Cerebral Ischemia research, save the paper, or map adjacent work.

Authors

Researchers on this paper

Retnaningsih Retnaningsih

first | Diponegoro University | ORCID 0000-0003-1072-6123

Dodik Tugasworo

middle | Diponegoro University | ORCID 0000-0001-6193-5828

Wati Arinta Puspita

middle | Diponegoro University

Chandra Elvika

middle | Diponegoro University

Arrizki Azka Pratama

last | Diponegoro University | ORCID 0009-0004-0675-0395

Research areas

Follow related topics

Citation

BibTeX

@article{Retnaningsih2026Cytoflavin,
  title = {Cytoflavin's neuroprotective effect in acute ischemic stroke: a systematic review and meta-analysis},
  author = {Retnaningsih Retnaningsih and Dodik Tugasworo and Wati Arinta Puspita and Chandra Elvika and Arrizki Azka Pratama},
  journal = {Frontiers in Stroke},
  year = {2026},
  doi = {10.3389/fstro.2026.1775376},
  url = {https://doi.org/10.3389/fstro.2026.1775376}
}

FAQ

Using this paper in a discovery workflow

How do I find related work for this paper?

Use the related papers and topic links on this page as starting points. In Scollr, you can also open the paper and build a literature map around its references, citing papers, and related work.

How can I keep up with new Neuroprotection in Cerebral Ischemia research papers?

Follow Neuroprotection in Cerebral Ischemia research in Scollr. New papers from the topic flow into a personalized feed, and you can save useful studies to revisit later.

Can I cite this paper from this page?

This page includes a static BibTeX block for Cytoflavin's neuroprotective effect in acute ischemic stroke: a systematic review and meta-analysis. Always verify the DOI, source, and publication details against the publisher record before submitting a manuscript.

Follow this research in Scollr

Follow the topics and authors behind this paper, save useful studies, and build a literature map when you are ready to go deeper.

Get the app